Antibody-Drug Conjugate Prolongs Survival in Metastatic Breast Cancer

Positive outcome with sacituzumab govitecan leads to questions about ADC sequencing

Related Keywords

United States ,Hebron ,Israel General ,Israel ,Paris ,France General ,France ,Barcelona ,Comunidad Autonoma De Cataluna ,Spain ,American ,Charles Bankhead ,Meritxell Bellet Ezquerra ,American Society Of Clinical Oncology ,Hebron Institute Of Oncology ,University Of California San Francisco ,European Society For Medical Oncology ,California San Francisco ,European Society ,Medical Oncology ,Hebron Institute ,American Society ,Clinical Oncology ,Medpage Today ,